Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Lamin C protein deficiency in the primary fibroblasts from a new laminopathy case with ovarian cystadenoma.

Cai MY, Liang H, Li M, Bi Y, Chen X, Sun WP, Weng JP.

Chin Med J (Engl). 2010 Aug;123(16):2237-43.

PMID:
20819672
2.

Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction.

Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT.

J Clin Invest. 2004 Feb;113(3):370-8.

3.

[The atypical of Werner syndrome: effect of laminopathy].

Smirnova NV, Spivak IM, Pleskach NM, Mikhel'son VM.

Tsitologiia. 2008;50(9):780-7. Russian.

PMID:
18959190
4.

Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.

Muchir A, Medioni J, Laluc M, Massart C, Arimura T, van der Kooi AJ, Desguerre I, Mayer M, Ferrer X, Briault S, Hirano M, Worman HJ, Mallet A, Wehnert M, Schwartz K, Bonne G.

Muscle Nerve. 2004 Oct;30(4):444-50.

PMID:
15372542
5.

Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism?

Ben Yaou R, Toutain A, Arimura T, Demay L, Massart C, Peccate C, Muchir A, Llense S, Deburgrave N, Leturcq F, Litim KE, Rahmoun-Chiali N, Richard P, Babuty D, Récan-Budiartha D, Bonne G.

Neurology. 2007 May 29;68(22):1883-94.

PMID:
17536044
6.

Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A.

Galiová G, Bártová E, Raska I, Krejcí J, Kozubek S.

Eur J Cell Biol. 2008 May;87(5):291-303. doi: 10.1016/j.ejcb.2008.01.013. Epub 2008 Apr 8.

PMID:
18396346
7.

Cell-cycle-dependent dynamics of nuclear pores: pore-free islands and lamins.

Maeshima K, Yahata K, Sasaki Y, Nakatomi R, Tachibana T, Hashikawa T, Imamoto F, Imamoto N.

J Cell Sci. 2006 Nov 1;119(Pt 21):4442-51.

8.

Altered protein dynamics of disease-associated lamin A mutants.

Gilchrist S, Gilbert N, Perry P, Ostlund C, Worman HJ, Bickmore WA.

BMC Cell Biol. 2004 Dec 13;5(1):46.

9.

Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.

Kandert S, Lüke Y, Kleinhenz T, Neumann S, Lu W, Jaeger VM, Munck M, Wehnert M, Müller CR, Zhou Z, Noegel AA, Dabauvalle MC, Karakesisoglou I.

Hum Mol Genet. 2007 Dec 1;16(23):2944-59. Epub 2007 Sep 19. Erratum in: Hum Mol Genet. 2008 Feb 1;17(3):468.

PMID:
17881656
10.

A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C.

Ivorra C, Kubicek M, González JM, Sanz-González SM, Alvarez-Barrientos A, O'Connor JE, Burke B, Andrés V.

Genes Dev. 2006 Feb 1;20(3):307-20. Erratum in: Genes Dev. 2006 Mar 15;20(6):747.

11.

X-linked Emery-Dreifuss muscular dystrophy with lamin A deficiency and IBM inclusions.

Fidzianska A, Niebrój-Dobosz I, Madej-Pilarczyk A, Duong NT, Wehnert M.

Clin Neuropathol. 2010 Mar-Apr;29(2):78-83.

PMID:
20175956
12.

Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.

Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN, LaPushin R, Andreeff M, Fang B, Yu Y, Bast RC Jr.

Cancer Res. 2002 Dec 15;62(24):7264-72.

13.

Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription.

Capanni C, Cenni V, Mattioli E, Sabatelli P, Ognibene A, Columbaro M, Parnaik VK, Wehnert M, Maraldi NM, Squarzoni S, Lattanzi G.

Exp Cell Res. 2003 Nov 15;291(1):122-34.

PMID:
14597414
14.

Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis.

Lee SH, Zhang W, Choi JJ, Cho YS, Oh SH, Kim JW, Hu L, Xu J, Liu J, Lee JH.

Oncogene. 2001 Oct 11;20(46):6700-6. Erratum in: Oncogene 2002 Aug 22;31(27):5822. Lee SH [corrected to Oh SH].

15.

Increased solubility of lamins and redistribution of lamin C in X-linked Emery-Dreifuss muscular dystrophy fibroblasts.

Markiewicz E, Venables R, Mauricio-Alvarez-Reyes, Quinlan R, Dorobek M, Hausmanowa-Petrucewicz I, Hutchison C.

J Struct Biol. 2002 Oct-Dec;140(1-3):241-53.

PMID:
12490172
16.

Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.

Han X, Feng X, Rattner JB, Smith H, Bose P, Suzuki K, Soliman MA, Scott MS, Burke BE, Riabowol K.

Nat Cell Biol. 2008 Nov;10(11):1333-40. doi: 10.1038/ncb1792. Epub 2008 Oct 5.

PMID:
18836436
17.

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.

Cancer Res. 1996 Feb 1;56(3):556-62.

18.
19.

"Pseudoascites" secondary to an amylase-producing serous ovarian cystadenoma. A case study.

Brophy CM, Morris J, Sussman J, Modlin IM.

J Clin Gastroenterol. 1989 Dec;11(6):703-6.

PMID:
2479672
20.

Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology.

Mandai M, Konishi I, Kuroda H, Komatsu T, Yamamoto S, Nanbu K, Matsushita K, Fukumoto M, Yamabe H, Mori T.

Hum Pathol. 1998 Jan;29(1):34-40.

PMID:
9445131

Supplemental Content

Support Center